Skip to main content
CriticalFDAfda-F-1438-2019UNDECLARED ALLERGEN

Gia Russa Whole Grain Italian Seasoned Bread Crumbs in 10 Oz Paperboard Canisters

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Units Affected
16
Recall Date
May 3, 2019
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1438-2019.

Product contains undeclared Allergens: Walnuts & Pecans

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1438-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Icco Cheese Co Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1438-2019.

Icco Cheese Co Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Icco Cheese Co Inc Recall FAQ

Icco Cheese Co Inc is the subject of a bakery & grains safety report: Gia Russa Whole Grain Italian Seasoned Bread Crumbs in 10 Oz Paperboard Canisters. The notice was published on May 3, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 16 units are potentially affected.